Ottawa Hospital Research Institute: HIV Infections trials

The registry lists 11 HIV Infections studies with Ottawa Hospital Research Institute as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 3Phase 2 2Phase 3 3No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV InfectionRecruitingNCT03147859Phase 2
• Combination Vaccination Before HIV Treatment InterruptionCompletedNCT00212888Phase 1/2Results posted
• RA Effect on Cell Surface Molecules in VivoWithdrawnNCT03753867Phase 1
• HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-InfectionCompletedNCT02660905Phase 3
• Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic StudyCompletedNCT02034838Phase 1
• Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA KitCompletedNCT01344642
• Micronutrients and Antioxidants in HIV InfectionCompletedNCT00798772Not applicable
• Kaletra Monotherapy in HIV/HCV Co-infected SubjectsCompletedNCT00508222Phase 3
• Multicenter Trial of Immunologic Markers to Predict Long Term Virologic OutcomesCompletedNCT00440206
• A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infectionWithdrawnNCT00414414Phase 3
• Supportive Therapy for Adherence to ART(STAART)CompletedNCT00212940Not applicable